September 22, 2022

Information for people on methadone and health care providers about new generic methadone products

Two new generic methadone products have been added to the Ontario provincial formulary. As of Septem

May 30, 2022

Take-home Naloxone Program in EDs and Hospitals

These materials are intended for EDs and hospitals who want to set up their own take-home naloxone p

April 19, 2022

Take-Home Naloxone Bulletin

The Ontario Naloxone Program (ONP) and META:PHI have prepared a bulletin on the importance of making

February 10, 2022

Looking for META:PHI community consultants

In order to improve the quality and credibility of our materials, META:PHI would like to assemble a


Latest resources

WMS Manual
Withdrawal management services manual

Created by Katie Dunham NP-PHC, Mareena Mathew NP-Adult, Karan Cheema NP-PHC, Laura Jones NP-Adult, Kristine Rivest NP-PHC, Jared Bonis NP-PHC, Meldon Kahan MD, and Jennifer Wyman MD (version date: February 2022).

COVID-19 Resources
Opioid agonist treatment guidance (in collaboration with the Centre for Addiction and Mental Health and the Ontario Medical Association)

Version date: August 2021

PDF, 271kB
Primary care management of substance use

Version date: 12 August 2021

PDF, 751kB
Methadone treatment for people who use fentanyl: Recommendations

The first in a series of guidance documents on OAT for people who use fentanyl. Created by Lisa Bromley MD, Meldon Kahan MD, Leonora Regenstreif MD, Anita Srivastava MD, and Jennifer Wyman MD (version date: 30 June 2021).

PDF, 416kB